The earnings call highlighted significant growth and expansion in international markets, driven by strategic investments and product innovation. However, domestic challenges persist, with revenue declines and pricing pressures affecting overall performance. Despite these challenges, Curaleaf remains optimistic about future growth opportunities and regulatory reforms.

Company Guidance -

Q3 2025

During the second quarter of 2025, Curaleaf Holdings reported a revenue of $315 million, reflecting a 1.5% increase compared to the first quarter, aligning with their guidance for low single-digit growth. Despite price compression, the International segment showed strong performance with a 17% sequential growth. The company's adjusted gross margin stood at 49%, down 130 basis points from the prior quarter due to promotional activities. Adjusted EBITDA was $66 million, with a 21% adjusted EBITDA margin. Curaleaf closed the quarter with $102 million in cash, after $47 million in interest and debt payments, and generated $9 million in operating cash flow. The company is preparing for strategic moves involving potential spinning off of international and hemp businesses if U.S. federal reform does not progress. Curaleaf's international segment, notably in Germany and the U.K., continues to grow, with a 62% year-over-year revenue increase, and the company is expanding its presence in new markets such as Turkey.

International Segment Growth

The International segment impressed with a solid quarter, achieving 17% sequential growth and 62% year-over-year growth, driven by strong demand in Germany and the U.K.

Product Innovation and Expansion

Curaleaf launched several new products, including ACE (Aqueous Cannabis Extraction oil) and Anthem pre-rolls, which are showing strong performance. Anthem is the fastest-growing pre-roll brand in New York.

Record Growth in German Market

Germany saw a fourfold increase in imported cannabis flower, with Curaleaf benefiting from robust patient growth post-CanG Act.

Expansion into New Markets

Curaleaf received a license to enter the Turkish market, offering a first-mover advantage in the nascent medical cannabis market. They also achieved EU medical device registration for a cannabis inhalation device.

Curaleaf Holdings (TSE:CURA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TSE:CURA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 10, 2025	2025 (Q3)	-0.10 / -	-0.096	―	―	―
Aug 06, 2025	2025 (Q2)	-0.08 / -0.08	-0.082	0.00% (0.00)	―
May 08, 2025	2025 (Q1)	-0.09 / -0.10	-0.096	0.00% (0.00)	―
Mar 03, 2025	2024 (Q4)	-0.09 / -0.14	-0.11	-25.00% (-0.03)	―
Nov 06, 2024	2024 (Q3)	-0.09 / -0.10	-0.124	22.22% (+0.03)	―
Aug 07, 2024	2024 (Q2)	-0.08 / -0.08	-0.124	33.33% (+0.04)	―
May 09, 2024	2024 (Q1)	-0.08 / -0.10	-0.069	-40.00% (-0.03)	―
Mar 06, 2024	2023 (Q4)	-0.07 / -0.11	-0.495	77.78% (+0.38)	―
Nov 09, 2023	2023 (Q3)	-0.09 / -0.12	-0.096	-28.57% (-0.03)	―
Aug 09, 2023	2023 (Q2)	-0.06 / -0.12	-0.055	-125.00% (-0.07)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TSE:CURA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	C$2.31	C$2.41	+4.33%
May 08, 2025	C$1.21	C$1.14	-5.79%
Mar 03, 2025	C$1.75	C$1.52	-13.14%
Nov 06, 2024	C$3.04	C$3.09	+1.64%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Curaleaf Holdings (TSE:CURA) report earnings?

Curaleaf Holdings (TSE:CURA) is schdueled to report earning on Nov 10, 2025, After Close (Confirmed).

What is Curaleaf Holdings (TSE:CURA) earnings time?

Curaleaf Holdings (TSE:CURA) earnings time is at Nov 10, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TSE:CURA EPS forecast?

TSE:CURA EPS forecast for the fiscal quarter 2025 (Q3) is -0.1.

Curaleaf Holdings (TSE:CURA) Earnings News

Curaleaf (TSE:CURA) Misses Q3-2022 Earnings Estimates, but There’s Potential Here

Premium

Market News

Curaleaf (TSE:CURA) Misses Q3-2022 Earnings Estimates, but There’s Potential Here

3y ago

See More TSE:CURA News >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing